Market Overview

UPDATE: Goldman Sachs Downgrades Intuitive Surgical on Disappointing 2Q2013 Results

Related ISRG
What's Powering This Robotics ETF
Lightning Round: Jim Cramer Give His Opinion On American Express, CME Group And More

In a report published on Tuesday, Goldman Sachs analyst David H. Roman downgraded Intuitive Surgical (NASDAQ: IRSG) to Neutral and lowered the price target to $500 from $676.

In the report, Goldman Sachs noted, "While procedure volumes were somewhat better than most had feared (no material change in growth vs. Q1), the US capital equipment business looks to be facing material incremental headwinds".

Intuitive Surgical closed on Monday at $500.08.

Latest Ratings for ISRG

Oct 2017CitigroupMaintainsBuy
Oct 2017BarclaysMaintainsOverweight
Oct 2017Morgan StanleyMaintainsOverweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: David H. Roman Goldman SachsAnalyst Color Downgrades Analyst Ratings


Related Articles (ISRG)

View Comments and Join the Discussion!

Partner Center